Outcomes of SARS-CoV-2 Infection in Patients With Chronic Liver Disease and Cirrhosis: A National COVID Cohort Collaborative Study

Medicine & Life Sciences

• Coronavirus Infections 100%
• Severe Acute Respiratory Syndrome 90%
• Liver Cirrhosis 64%
• Liver Diseases 58%
• Chronic Disease 51%
• Cohort Studies 47%
• Fibrosis 44%
• Coronavirus 23%
• Mortality 9%
• Electronic Health Records 4%
• Survival Analysis 4%
• Lung Diseases 4%
• Heart Diseases 3%
• Vaccination 3%
• Datasets 3%
• Vaccines 3%
• Heart Failure 3%
• Obesity 3%
• Health Care Outcome Assessment 3%